T
246710
vs
K
KOSPI 200
Over the past 12 months, T&R Biofab Co Ltd has underperformed KOSPI 200, delivering a return of +0% compared to KOSPI 200's +112% growth.
Stocks Performance
246710 vs KOSPI 200
Performance Gap
246710 vs KOSPI 200
Performance By Year
246710 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
T&R Biofab Co Ltd
Glance View
T&R Biofab Co Ltd makes 3D bioprinting systems and bioinks for research and tissue-engineering work. Its products are used to build and test living tissue structures, such as skin and other lab-made biological models, rather than to make finished consumer goods. The company mainly serves hospitals, universities, research institutes, and biotech and pharmaceutical firms that need tools for drug testing, disease research, and regenerative medicine. It earns money by selling bioprinters, related consumables such as bioinks and printing materials, and sometimes custom development or support services tied to those systems. This means part of its business is a recurring consumables model: customers buy the equipment first and then keep purchasing materials to run experiments. That makes the company different from a standard medical device maker because it sits at the point where hardware, biology, and lab research meet. Its role in the industry is to give researchers the tools to create more realistic tissue models without relying only on animal testing or simple cell cultures. If its systems are adopted widely, the company can become a key supplier in the early-stage workflow of tissue engineering and preclinical testing. In simple terms, it sells the machines and materials that let scientists print living tissue models in the lab.
